Improving Physical Activity Levels in the Arabic- Speaking Residents of East Jerusalem With Prediabetes
1 other identifier
interventional
375
0 countries
N/A
Brief Summary
This three-arm clinical trial aims to improve levels of physical activity among Arabic- speaking residents of East Jerusalem with prediabetes. Levels of daily physical activity (assessed through activity trackers), dietary habits and self-assessed health will be compared between patients that receive only the activity tracker and written information (group A), receive the activity tracker, written information and a personalized physical activity prescription (group B), and those that receive in addition also intensive follow-up with motivational interview by physician assistants and a dietitian (group C)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable diabetes-mellitus
Started Feb 2019
Typical duration for not_applicable diabetes-mellitus
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 24, 2019
CompletedFirst Posted
Study publicly available on registry
January 29, 2019
CompletedStudy Start
First participant enrolled
February 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2021
CompletedFebruary 5, 2019
February 1, 2019
2 years
January 24, 2019
February 3, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Physical activity level assessed through average weekly steps
six months
Secondary Outcomes (13)
Fasting glucose levels
six months
HbA1C levels
six months
Body Mass Index
six months
Lipid profile
six months
Blood pressure
six months
- +8 more secondary outcomes
Study Arms (3)
Group A
ACTIVE COMPARATORPatients will receive an activity tracker and written information for pre-diabetic, on top of their usual care.
Group B
ACTIVE COMPARATORPatients will receive an activity tracker, written information for pre-diabetic, and personalized physical activity prescription, on top of their usual care.
Group C
ACTIVE COMPARATORPatients will receive an activity tracker, written information for pre-diabetic, personalized physical activity prescription, three sessions of motivational interview support from trained physician assistants, and two session of dietitian support, on top of their usual care.
Interventions
Three sessions of a structured motivational support intervention. Each patient will be required to set a SMART physical activity personal objective. The sessions will cover possible barriers and facilitators, enhancing self-efficacy, and feedback. In addition two sessions with a dietitian to discuss ways to improve current health habits.
Each patient will receive their own activity tracker (vivofit 3) with instructions on use, in addition to usual care, and written handouts for pre-diabetic patients.
Each patient will receive a personalized prescription of recommended physical activity including type of activity, duration and frequency.
Eligibility Criteria
You may qualify if:
- Pre-diabetes patients - Impaired fasting glucose at least twice between 100-125 mg/dL in the two years prior to the study; or HbA1C 5.7%-6.4% twice in the two years prior to the study; or one test of fasting glucose of 100-125 mg/dL, and one test of HbA1C between 5.7%-6.4% in the two years prior to the study.
You may not qualify if:
- Diabetes including a doctor's diagnosis based on a medical file or a recurrence of fasting blood glucose values above 126 mg/dL in the year preceding the study or a glucose value greater than 200 mg/dL in the year prior to the study or HbA1C above 6.5%
- Treatment with diabetes drugs other than metformin, as prescribed in the medical file with regular or chronic medications
- Artificial lower limbs or inability to walk normally (eg: stroke with plegia)
- Chronic obstructive pulmonary disease
- Known heart disease (with impaired exercise tolerance)
- Pregnancy
- Medical conditions:
- a cardiac event/ Transient ischemic attack in the last year
- Cerebrovascular attack with residual impairment
- Surgery that required hospitalization in the last year
- Injury to lower limbs that prevents regular walking
- Malignancy excluding skin cancer small cell carcinoma or basal cell carcinoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Clalit Health Serviceslead
- Hebrew University of Jerusalemcollaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amnon Lahad, MD
Clalit
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Medical Quality unit and Chairman department of Family Medicine, Clalit Health Services, Jerusalem district
Study Record Dates
First Submitted
January 24, 2019
First Posted
January 29, 2019
Study Start
February 15, 2019
Primary Completion
February 15, 2021
Study Completion
August 31, 2021
Last Updated
February 5, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared